Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
Brown University
mi
from
Providence, RI
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Targeted Hypoglossal Neurostimulation Study #2
Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System
Status: Enrolling
Updated:  6/28/2013
Porter Adventist Hospital
mi
from
Denver, CO
Targeted Hypoglossal Neurostimulation Study #2
Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System
Status: Enrolling
Updated: 6/28/2013
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Targeted Hypoglossal Neurostimulation Study #2
Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System
Status: Enrolling
Updated:  6/28/2013
Chicago ENT
mi
from
Chicago, IL
Targeted Hypoglossal Neurostimulation Study #2
Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System
Status: Enrolling
Updated: 6/28/2013
Chicago ENT
mi
from
Chicago, IL
Click here to add this to my saved trials
Targeted Hypoglossal Neurostimulation Study #2
Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System
Status: Enrolling
Updated:  6/28/2013
Orange Regional Medical Center
mi
from
Middletown, NY
Targeted Hypoglossal Neurostimulation Study #2
Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System
Status: Enrolling
Updated: 6/28/2013
Orange Regional Medical Center
mi
from
Middletown, NY
Click here to add this to my saved trials
Homeopathic Cold Remedy for Children Study
Randomized Controlled Trial of a Homeopathic Cold Remedy for Children
Status: Enrolling
Updated:  7/9/2013
University of Washington Medical Center-Roosevelt Pediatric Care Center
mi
from
Seattle, WA
Homeopathic Cold Remedy for Children Study
Randomized Controlled Trial of a Homeopathic Cold Remedy for Children
Status: Enrolling
Updated: 7/9/2013
University of Washington Medical Center-Roosevelt Pediatric Care Center
mi
from
Seattle, WA
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative Site
mi
from
Birmingham, AL
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative site
mi
from
Los Angeles, CA
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative Site
mi
from
Miami, FL
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative Site
mi
from
Las Vegas, NV
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative Site
mi
from
High Point, NC
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative Site
mi
from
High Point, NC
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative Site
mi
from
Mt. Pleasant, SC
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative Site
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative Site
mi
from
Knoxville, TN
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated:  7/9/2013
Novartis Investigative site
mi
from
Dallas, TX
NVA237 Versus Placebo 12-week Efficacy Study
A 12-week Multi-center, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of NVA237 in Stable COPD Patients
Status: Enrolling
Updated: 7/9/2013
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function
Innate and Adaptive Immunity in COPD Exacerbations: Clinically-Indicated Bronchoscopies
Status: Enrolling
Updated:  7/15/2013
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function
Innate and Adaptive Immunity in COPD Exacerbations: Clinically-Indicated Bronchoscopies
Status: Enrolling
Updated: 7/15/2013
University of Michigan at Ann Arbor
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
TruFreeze™ Airway Obstruction: TAO STUDY
A PROSPECTIVE, MULTI-CENTER PILOT STUDY OF THE truFREEZE™ SYSTEM TO ASSESS THE EFFICACY AND SAFETY OF CRYO SPRAY ABLATION IN THE TREATMENT OF AIRWAY OBSTRUCTIONS (TruFreeze AIRWAY OBSTRUCTION - "TAO" STUDY)
Status: Enrolling
Updated:  7/19/2013
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
TruFreeze™ Airway Obstruction: TAO STUDY
A PROSPECTIVE, MULTI-CENTER PILOT STUDY OF THE truFREEZE™ SYSTEM TO ASSESS THE EFFICACY AND SAFETY OF CRYO SPRAY ABLATION IN THE TREATMENT OF AIRWAY OBSTRUCTIONS (TruFreeze AIRWAY OBSTRUCTION - "TAO" STUDY)
Status: Enrolling
Updated: 7/19/2013
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
TruFreeze™ Airway Obstruction: TAO STUDY
A PROSPECTIVE, MULTI-CENTER PILOT STUDY OF THE truFREEZE™ SYSTEM TO ASSESS THE EFFICACY AND SAFETY OF CRYO SPRAY ABLATION IN THE TREATMENT OF AIRWAY OBSTRUCTIONS (TruFreeze AIRWAY OBSTRUCTION - "TAO" STUDY)
Status: Enrolling
Updated:  7/19/2013
Franklin Square Medical Center
mi
from
Baltimore, MD
TruFreeze™ Airway Obstruction: TAO STUDY
A PROSPECTIVE, MULTI-CENTER PILOT STUDY OF THE truFREEZE™ SYSTEM TO ASSESS THE EFFICACY AND SAFETY OF CRYO SPRAY ABLATION IN THE TREATMENT OF AIRWAY OBSTRUCTIONS (TruFreeze AIRWAY OBSTRUCTION - "TAO" STUDY)
Status: Enrolling
Updated: 7/19/2013
Franklin Square Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
TruFreeze™ Airway Obstruction: TAO STUDY
A PROSPECTIVE, MULTI-CENTER PILOT STUDY OF THE truFREEZE™ SYSTEM TO ASSESS THE EFFICACY AND SAFETY OF CRYO SPRAY ABLATION IN THE TREATMENT OF AIRWAY OBSTRUCTIONS (TruFreeze AIRWAY OBSTRUCTION - "TAO" STUDY)
Status: Enrolling
Updated:  7/19/2013
Boston Med Center
mi
from
Boston, MA
TruFreeze™ Airway Obstruction: TAO STUDY
A PROSPECTIVE, MULTI-CENTER PILOT STUDY OF THE truFREEZE™ SYSTEM TO ASSESS THE EFFICACY AND SAFETY OF CRYO SPRAY ABLATION IN THE TREATMENT OF AIRWAY OBSTRUCTIONS (TruFreeze AIRWAY OBSTRUCTION - "TAO" STUDY)
Status: Enrolling
Updated: 7/19/2013
Boston Med Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated:  7/31/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated: 7/31/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated:  7/31/2013
Pfizer Investigational Site
mi
from
Biloxi, MS
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated: 7/31/2013
Pfizer Investigational Site
mi
from
Biloxi, MS
Click here to add this to my saved trials
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated:  7/31/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated: 7/31/2013
Pfizer Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated:  7/31/2013
Pfizer Investigational Site
mi
from
Houston, TX
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated: 7/31/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated:  7/31/2013
Pfizer Investigational Site
mi
from
Burke, VA
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
A Prospective, Open-Label, Non-Randomized, Multi-Center Study To Investigate The Safety And Tolerability Of Voriconazole As Primary Therapy For Treatment Of Invasive Aspergillosis And Molds Such As Scedosporium Or Fusarium Species In Pediatric Patients
Status: Enrolling
Updated: 7/31/2013
Pfizer Investigational Site
mi
from
Burke, VA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Birmingham, AL
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Bettendorf, IA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Louisville, KY
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Metairie, LA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Baltimore, MD
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Boston, MA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Omaha, NE
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
New York, NY
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Ashville, NC
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Cleveland, OH
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Charleston, SC
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Dallas, TX
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Norfolk, VA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Seattle, WA
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Huntington, WV
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Huntington, WV
Click here to add this to my saved trials
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated:  8/8/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation
Status: Enrolling
Updated: 8/8/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects
A Randomized, Single Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Repeat Escalating Oral Doses of GSK2140944 in Healthy Adult Subjects (BTZ116778)
Status: Enrolling
Updated:  8/8/2013
GSK Investigational Site
mi
from
Westwood, KA
This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects
A Randomized, Single Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Repeat Escalating Oral Doses of GSK2140944 in Healthy Adult Subjects (BTZ116778)
Status: Enrolling
Updated: 8/8/2013
GSK Investigational Site
mi
from
Westwood, KA
Click here to add this to my saved trials
Intensive Nutrition in ARDS: A Clinical Trial (INTACT)
Intensive Nutrition in ARDS: A Clinical Trail (INTACT)
Status: Enrolling
Updated:  8/12/2013
Rush University Medical Center
mi
from
Chicago, IL
Intensive Nutrition in ARDS: A Clinical Trial (INTACT)
Intensive Nutrition in ARDS: A Clinical Trail (INTACT)
Status: Enrolling
Updated: 8/12/2013
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials